Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Selegiline Hydrochloride Tablets

Approval Number

国药准字HJ20160342

CompanyORION CORPORATION

Registration Date

November 17, 2020

Previous Approval Numbers

H20160342

Drug Information

Generic Name

盐酸司来吉兰片

Trade Name

咪多吡

Brand Name

咪多吡

Dosage Form

片剂

Strength

5mg

Drug Type

化学药品

Registration Date

November 17, 2020

Expiry Date

November 16, 2025

Company Information

Applicant Company

Company NameORION CORPORATION

Company Address

Orionintie 1,02200 Espoo, Finland

Manufacturing Company

Company NameORION CORPORATION

Company Address

Tengstrominkatu 8, 20360 Turku, Finland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy